Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma.

1 Jun 1996

Abstract excerpt

Many human tumor cells have been shown to express antigens that are recognized by autologous cytotoxic T lymphocytes (CTL) and the molecular nature of a number of melanoma antigens has been defined recently. Here we describe the characterization of an antigen recognized on a renal cell carcinoma by autologous CTL clones. This antigen is encoded by the HLA-A2 gene present in the tumor cells. The sequence of this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic factors in colorectal cancer
Share to Immunotherapy and Immune Responses
Share to T-cell and B-cell Immunology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 8676070
DOI: 10.1084/jem.183.6.2501

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma.PMID 8676070Read ↗

A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinomaSemantic proximity Read ↗

Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes.Semantic proximity Read ↗

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.Semantic proximity Read ↗

Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypesSemantic proximity Read ↗

Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T LymphocytesSemantic proximity Read ↗

Limited regions of the alpha 2-domain alpha-helix control anti-A2 allorecognition: an analysis using a panel of A2 mutants.Semantic proximity Read ↗

Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cells.Semantic proximity Read ↗

Localization and characterization of serologic epitopes on HLA-A2.Semantic proximity Read ↗

Induction of human cytotoxic T lymphocytes specific for prostate-specific antigenSemantic proximity Read ↗

Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2.Semantic proximity Read ↗

Restoration of CTL recognition of a mutant FMP peptide by a compensatory change in HLA-A2.Semantic proximity Read ↗

Levels of Specific Peptide-HLA Class I Complex Predicts Tumor Cell Susceptibility to CTL KillingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.